- Apr 11, 2023
- FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing
- Mar 8, 2023
- Fujifilm Introduces Synapse® Pathology at the United States and Canadian Academy of Pathology Annual Meeting
- Feb 8, 2023
- Fujifilm’s Synapse® Vendor Neutral Archive (VNA) Ranks "Best in KLAS" for the Fourth Consecutive Year
- Jan 25, 2023
- Fujifilm Completes Asset Purchase Agreement of Inspirata, Inc.’s Digital Pathology Business
- Jan 10, 2023
- FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
- Jan 5, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- Dec 19, 2022
- Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
- Dec 13, 2022
- Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund
- Dec 6, 2022
- Shenandoah Biotechnology Introduces Expanded Range of CTGrade Recombinant Proteins Manufactured Following cGMP Practices
- Nov 22, 2022
- Fujifilm’s ARIETTA 650 DeepInsight™ Ultrasound System Now in Clinical Use at Multiple United Medical Imaging Healthcare Facilities
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Nov 21, 2022
- Fujifilm Unveils Latest Version of the Synapse® 7x Enterprise Imaging Platform at the 2022 Radiological Society of North America Annual Meeting
- Nov 21, 2022
- Fujifilm Showcases Cloud-based Synapse® Enterprise Imaging Portfolio at the 2022 Radiological Society of North America Annual Meeting
- Nov 21, 2022
- Fujifilm to Unveil New Medical Imaging Advances at the RSNA 2022 Conference
- Nov 15, 2022
- FUJIFILM Diosynth Biotechnologies Expands Strategic Partnership with NC State
- Nov 8, 2022
- Fujifilm Introduces SCENARIA View Focus Edition CT Scanner with Cardio StillShot, a new Cardiac Motion Correction Feature
- Oct 27, 2022
- FUJIFILM Diosynth Biotechnologies Enters Into an Agreement with Argenx to Manufacture Efgartigimod, a monoclonal antibody (mAb) for the Treatment of Severe Autoimmune Diseases
- Oct 25, 2022
- FUJIFILM Diosynth Biotechnologies Held Groundbreaking Celebration for Expansion of its Single-Use Manufacturing Campus in Texas
- Oct 24, 2022
- FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to enable GMP Manufacturing of Cell and Exosome Therapies
- Oct 20, 2022
- Fujifilm Unveils Premium Endoscopic Ultrasound Innovations at the American College of Gastroenterology’s 2022 Annual Scientific Meeting